-
What's Hot in Hematologic Malignancies
Dr Bruce Cheson gives a sneak preview of the presentations in hematologic malignancies at ASCO 2016, with a look at new agents, refined combinations, and strategies to reduce toxicities.
Medscape Oncology, May 27, 2016
-
Predicting Colon Cancer Relapse: Test Gets an 'A'
Dr David Kerr reviews new research on a molecular test that can help determine which patients should receive adjuvant chemotherapy for early-stage colon cancer.
Medscape Oncology, August 8, 2016
-
Lung Cancer Sessions Focus on Immunotherapy, Genomics
From diagnosis using molecular markers to targeted treatment, Dr Mark Kris details which studies from ASCO 2016 he thinks will help clinicians and patients fight lung cancer.
Medscape Oncology, June 1, 2016
-
What to Watch in Gynecologic Cancer
Dr Maurie Markman discusses some of the presentations on gynecologic malignancies at this year's ASCO meeting that he thinks will be the most interesting and provocative.
Medscape Oncology, June 1, 2016
-
12 Chemo Cycles: More Toxicity Than Therapy?
Dr John Marshall suggests that 12 cycles of chemotherapy in metastatic colorectal cancer exceeds what is needed for maximum tumor regression and often results in toxicity that is better avoided.
Medscape Oncology, July 25, 2016
-
Vitamin D: A New Intervention for Melanoma?
Does the association of low vitamin D levels and poor outcomes in melanoma patients point to supplementation as a potential intervention for melanoma?
Medscape Oncology, July 29, 2016
-
Iconoclastic Breast Surgeon Laura Esserman Challenges the Status Quo
From screening to treatment, breast cancer specialist Laura Esserman is on a quest to individualize patient care, and in doing so she is challenging a number of long-standing practices in cancer care.
Medscape, August 8, 2016
